Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Johnston

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Chemical Information and Modeling|April 7, 2020
Deep Dive into Machine Learning Models for Protein EngineeringYuting Xu, Deeptak Verma, Robert P Sheridan, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|March 5, 2008
Stress management versus lifestyle modification on systolic hypertension and medication elimination: a randomized trialJeffery A Dusek, Patricia L Hibberd, Beverly Buczynski, et al.
Nature Communications|November 16, 2024
A non-canonical mechanism of GPCR activationAlexander S Powers, Aasma Khan, Joseph M Paggi, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
A non-canonical mechanism of GPCR activationAlexander S Powers, Aasma Khan, Joseph M Paggi, et al.
Journal of Medicinal Chemistry|July 19, 2022
Discovery and Structure-Based Design of Macrocyclic Peptides Targeting STUB1Simon Ng, Alexander C Brueckner, Soheila Bahmanjah, et al.
The Journal of Biological Chemistry|July 13, 2026
A covalent inhibitor targeting Cys-349 of LIMK1 confers selectivity over LIMK2Jon B Patteson, Ioannis Manolaridis, Mee Ra Hong, et al.
Nature Structural & Molecular Biology|June 6, 2017
Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40Jun Lu, Noel Byrne, John Wang, et al.
Cell Chemical Biology|October 27, 2019
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, et al.
Circulation|May 1, 2023
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein ReceptorDouglas G Johns, Louis-Charles Campeau, Puja Banka, et al.
Journal of Medicinal Chemistry|May 27, 2026
Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SARHubert Josien, Anilkumar G Nair, Fa-Xiang Ding, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Chemical Information and Modeling|April 7, 2020
Deep Dive into Machine Learning Models for Protein EngineeringYuting Xu, Deeptak Verma, Robert P Sheridan, et al.
Journal of Alternative and Complementary Medicine (New York, N.Y.)|March 5, 2008
Stress management versus lifestyle modification on systolic hypertension and medication elimination: a randomized trialJeffery A Dusek, Patricia L Hibberd, Beverly Buczynski, et al.
Nature Communications|November 16, 2024
A non-canonical mechanism of GPCR activationAlexander S Powers, Aasma Khan, Joseph M Paggi, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
A non-canonical mechanism of GPCR activationAlexander S Powers, Aasma Khan, Joseph M Paggi, et al.
Journal of Medicinal Chemistry|July 19, 2022
Discovery and Structure-Based Design of Macrocyclic Peptides Targeting STUB1Simon Ng, Alexander C Brueckner, Soheila Bahmanjah, et al.
The Journal of Biological Chemistry|July 13, 2026
A covalent inhibitor targeting Cys-349 of LIMK1 confers selectivity over LIMK2Jon B Patteson, Ioannis Manolaridis, Mee Ra Hong, et al.
Nature Structural & Molecular Biology|June 6, 2017
Structural basis for the cooperative allosteric activation of the free fatty acid receptor GPR40Jun Lu, Noel Byrne, John Wang, et al.
Cell Chemical Biology|October 27, 2019
From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9Whitney L Petrilli, Gregory C Adam, Roman S Erdmann, et al.
Circulation|May 1, 2023
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein ReceptorDouglas G Johns, Louis-Charles Campeau, Puja Banka, et al.
Journal of Medicinal Chemistry|May 27, 2026
Discovery Process of Enlicitide, a Highly Engineered Macrocyclic Peptide Therapeutic, through Issue-Driven Fragment-Based Synthetic Assembly and SARHubert Josien, Anilkumar G Nair, Fa-Xiang Ding, et al.
Pageof 3